Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.
ADVANCED SEARCH
Log in
Top
Trials
Published in: Trials 1/2011

Open Access 01-12-2011 | Study protocol

Collaborative community based care for people and their families living with schizophrenia in India: protocol for a randomised controlled trial

Authors: Sudipto Chatterjee, Morven Leese, Mirja Koschorke, Paul McCrone, Smita Naik, Sujit John, Hamid Dabholkar, Kimberley Goldsmith, Madhumitha Balaji, Mathew Varghese, Rangaswamy Thara, Vikram Patel, Graham Thornicroft, The COmmunity care for People with Schizophrenia in India (COPSI) group

Published in: Trials | Issue 1/2011

Login to get access

Abstract

Background

There is a large treatment gap with few community services for people with schizophrenia in low income countries largely due to the shortage of specialist mental healthcare human resources. Community based rehabilitation (CBR), involving lay health workers, has been shown to be feasible, acceptable and more effective than routine care for people with schizophrenia in observational studies. The aim of this study is to evaluate whether a lay health worker led, Collaborative Community Based Care (CCBC) intervention, combined with usual Facility Based Care (FBC), is superior to FBC alone in improving outcomes for people with schizophrenia and their caregivers in India.

Methods/Design

This trial is a multi-site, parallel group randomised controlled trial design in India.
The trial will be conducted concurrently at three sites in India where persons with schizophrenia will be screened for eligibility and recruited after providing informed consent. Trial participants will be randomly allocated in a 2:1 ratio to the CCBC+FBC and FBC arms respectively using an allocation sequence pre-prepared through the use of permuted blocks, stratified within site. The structured CCBC intervention will be delivered by trained lay community health workers (CHWs) working together with the treating Psychiatrist. We aim to recruit 282 persons with schizophrenia. The primary outcomes are reduction in severity of symptoms of schizophrenia and disability at 12 months. The study will be conducted according to good ethical practice, data analysis and reporting guidelines.

Discussion

If the additional CCBC intervention delivered by front line CHWs is demonstrated to be effective and cost-effective in comparison to usually available care, this intervention can be scaled up to expand coverage and improve outcomes for persons with schizophrenia and their caregivers in low income countries.

Trial registration

The trial is registered with the International Society for the Registration of Clinical Trials and the allocated unique ID number is ISRCTN 56877013.
Appendix
Available only for authorised users
Literature
1.
Thara R: Twenty-year course of schizophrenia: the Madras Longitudinal Study. Can J Psychiatry. 2004, 49 (8): 564-9.PubMed
2.
Kurihara T: Eleven-year clinical outcome of schizophrenia in Bali. Acta Psychiatr Scand. 2005, 112 (6): 456-62. 10.1111/j.1600-0447.2005.00604.x.CrossRefPubMed
3.
WHO: The global burden of disease 2004 update. 2008, Geneva: World Health Organization
4.
WHO: The World Health Report. Mental health: New Understanding, New Hope. 2001, Geneva: World Health Organization
5.
Thornicroft G, Tansella M: Components of a modern mental health service: a pragmatic balance of community and hospital care: overview of systematic evidence. Br J Psychiatry. 2004, 185: 283-90. 10.1192/bjp.185.4.283.CrossRefPubMed
6.
Jacob KS: Mental health systems in countries: where are we now?. Lancet. 2007, 370 (9592): 1061-77. 10.1016/S0140-6736(07)61241-0.CrossRefPubMed
7.
Chisholm D: Scale up services for mental disorders:A call to action. Lancet. 2007, Global Mental Health, 87-98.
8.
WHO, ILO and UNESCO: CBR:A strategy for rehabilitation, equalization of opportunities, poverty reduction and social inclusion of people with disabilities. 2004, WHO, Geneva
9.
Chatterjee S: Evaluation of a community-based rehabilitation model for chronic schizophrenia in rural India. Br J Psychiatry. 2003, 182: 57-62. 10.1192/bjp.182.1.57.CrossRefPubMed
10.
Chatterjee S: Outcomes of people with psychotic disorders in a community-based rehabilitation programme in rural India. Br J Psychiatry. 2009, 195 (5): 433-9. 10.1192/bjp.bp.108.057596.CrossRefPubMedPubMedCentral
11.
WHO: The ICD-10 classification of mental and behavioural disorders- Research and Diagnostic criteria. 1992, Geneva: World Health Organization
12.
Haro JM, Kamat SA, Ochoa S: The Clinical Global Impression-Schizophrenia Scale: a simple instrument to measure the diversity of symptoms present in schizophrenia. Acta Psychiatr Scand. 2003, 107 (Suppl (416)): 16-23. 10.1034/j.1600-0447.107.s416.5.x.CrossRef
13.
Carpenter TW: Decisional capacity for informed consent in schizophrenia research. Archives of general Psychiatry. 2000, 57: 533-538. 10.1001/archpsyc.57.6.533.CrossRefPubMed
14.
15.
Boutron I: Extending the CONSORT statement to randomized trials of nonpharmacologic treatment: explanation and elaboration. Ann Intern Med. 2008, 148 (4): 295-309.CrossRefPubMed
16.
Adams G: Patterns of intra-cluster correlation from primary care research to inform study design and analysis. J Clin Epidemiol. 2004, 57 (8): 785-94. 10.1016/j.jclinepi.2003.12.013.CrossRefPubMed
17.
Kay SR, Fiszbein A, Opler LA: The positive and negative syndrome scale (PANSS) for schizophrenia. Schizophr Bull. 1987, 13 (2): 261-76.CrossRefPubMed
18.
Thara R: Indian Disability Evaluation and Assessment Scale. 2002, R.C.o.I.P. Society
19.
Thornicroft G: Global pattern of experienced and anticipated discrimination against people with schizophrenia: a cross-sectional survey. Lancet. 2009, 373 (9661): 408-15. 10.1016/S0140-6736(08)61817-6.CrossRefPubMed
20.
TNS UK for the Care Services Improvement Partnership, D.o.H.: Attitudes to mental illness 2009 research report. 2009
21.
Boyd Ritcher J: Internalized stigma of mental illness: psychometric properties of a new measure. Psychiatric Research. 2003, 121: 31-49. 10.1016/j.psychres.2003.08.008.CrossRef
22.
Group E: EuroQol: a facility for the measurement of health-related quality of life. Health Policy. 1990, 16: 199-208. 10.1016/0168-8510(90)90421-9.CrossRef
23.
Thara R, Padmavathi R, Kumar S, Srinivasan L: Burden Assessment schedule: Instrument to assess burden on caregivers of chronic mentally ill. Indian Journal of Psychiatry. 1998, 40: 21-29.PubMedPubMedCentral
24.
Barrowclough C, Tarrier N, Watts S, Vaughn C, Bamrah JS, Freeman HL: Assessing the functional value of relatives' knowledge about schizophrenia: a preliminary report. British Journal of Psychiatry. 1985, 151: 1-8. 10.1192/bjp.151.1.1.CrossRef
25.
Sartorius N, Gulbinat G, Harrison G: Long term follow-up of schizophrenia in 16 countries. Social Psychiatry &Psychiatric Epidemiology. 1996, 31: 249-258.
26.
Thara R, TN S: How stigmatising is schizophrenia in India?. Int J Soc Psych. 2000, 46: 135-10.1177/002076400004600206.CrossRef
27.
Chisholm DSK, Kumar KK, Saeed K, James S, Mubbashar M: Integration of mental health care into primary care. Demonstration cost-outcome study in India and Pakistan. Br J Psychiatry. 2000, 176: 581-588. 10.1192/bjp.176.6.581.CrossRefPubMed
28.
Roberts C, Roberts SA: Design and analysis of clinical trials with clustering effects due to treatment Clin Trials. 2005, 2 (2): 152-62.PubMed
29.
Guideline IHT: Guideline for good clinical practice E6 (R1). in International conference on harmonization of technical requirements for registration of pharmaceuticals for human use. 1996
Metadata
Title
Collaborative community based care for people and their families living with schizophrenia in India: protocol for a randomised controlled trial
Authors
Sudipto Chatterjee
Morven Leese
Mirja Koschorke
Paul McCrone
Smita Naik
Sujit John
Hamid Dabholkar
Kimberley Goldsmith
Madhumitha Balaji
Mathew Varghese
Rangaswamy Thara
Vikram Patel
Graham Thornicroft
The COmmunity care for People with Schizophrenia in India (COPSI) group
Publication date
01-12-2011
Publisher
BioMed Central
Published in
Trials / Issue 1/2011
Electronic ISSN: 1745-6215
DOI
https://doi.org/10.1186/1745-6215-12-12

Other articles of this Issue 1/2011

Trials 1/2011 Go to the issue

Study protocol

Hand-suture versus stapling for closure of loop ileostomy: HASTA-Trial: a study rationale and design for a randomized controlled trial

Study protocol

A primary-school-based study to reduce prevalence of childhood obesity in Catalunya (Spain) - EDAL-Educació en alimentació: study protocol for a randomised controlled trial

Study protocol

Effectiveness of heat-sensitive moxibustion in the treatment of lumbar disc herniation: study protocol for a randomized controlled trial

Study protocol

A randomised controlled trial to compare opt-in and opt-out parental consent for childhood vaccine safety surveillance using data linkage: study protocol

Study protocol

Simultaneous use of traditional Chinese medicine (Si-Ni-Tang) to treat septic shock patients: study protocol for a randomized controlled trial

Study protocol

The utility of Aspirin in dukes C and high risk dukes B colorectal cancer - The ASCOLT study: study protocol for a randomized controlled trial